A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Subjects With Moderately to Severely Active Crohn's Disease
收藏DataCite Commons2025-12-20 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00004835/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The primary purpose of this study is to evaluate the efficacy and safety of 2 maintenance regimens of ustekinumab administered subcutaneously to patients with moderately to severely active Crohn's disease who responded to treatment with intravenous ustekinumab in studies CNTO1275CRD3001 and CNTO1275CRD3002, compared to subcutaneously administered placebo.
提供机构：
Vivli
创建时间：
2019-09-19
